Comparison of machine learning methods for clinical data imputation among a real-world lung cancer cohort

Author:

Yang Daniel X.,Hui Yongfeng,Wang Betsy,Avesta ArmanORCID,Zuber Charlotte,Park Henry S.,Aneja Sanjay

Abstract

AbstractPURPOSECancer registries are important sources of real-world data (RWD) that reveal insights into practice patterns and cancer patient outcomes, but the prevalence of missing data can be high. Machine learning (ML) imputation methods can be applied to large RWD sets, but the performance of these approaches within cancer registries is unclear.METHODSWe identified non-small cell lung cancer (NSCLC) patients within the National Cancer Database diagnosed in 2014 with complete data in 19 variables of known clinical and prognostic significance. We generated synthetic missing data for each variable, then performed imputation using substitution (control) and five different ML approaches. Imputation efficacy was measured by normalized root-mean-square error (RMSE) for continuous variables and proportion of falsely classified entries (PFC) for categorical variables. We also measured algorithm runtimes and the impact of incorporating imputed values on survival modeling.RESULTS50,790 NSCLC patients were included for this study, with 81 features for each patient after data preprocessing. Among the tested ML methods, SoftImpute had the lowest RMSE (best performance) for continuous variables ranging from 0.071 to 0.080 for 10% to 50% missing data, and MissForest had the lowest PFC (best performance) for categorical variables ranging from 0.251 to 0.311 for 10 to 50% missing data. SoftImpute had a runtime of 3.28×10−4 seconds per patient record, and MissForest averaged 2.96×10−3 seconds per patient record. Deep learning imputation using a denoising autoencoder did not achieve improved performance despite higher algorithm runtimes. Cox models incorporating ML imputed data achieved similar C-index ranging from 0.787 to 0.801 for all ML methods tested.CONCLUSIONML imputation achieved promising performance for NSCLC patients within a large national cancer registry.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3